StreetAlpha.app
Home › Stocks › WST

West Pharmaceutical Services Inc (WST)

Healthcare
$390.30
▼ −1.61%
LAST CLOSE · NOV 20

West makes packaging, containment, and drug delivery systems for injectable medicines, plus contract-manufactured medical devices. It last closed at $390.30 on Nov 20, down 1.61% on the day. The next earnings report for WST is expected around Thu, Feb 11, 2027. For the quarter ended Sep 2026, WST reported EPS of $3.02 on revenue of $874.5M, with revenue up 8.7% from a year ago. Over its last 8 reports the stock moved an average of 11.7% the session after earnings. Over the last 12 months WST insiders bought $0 of stock on the open market and sold $6.6M, according to SEC Form 4 filings.

AI Auto Pilots
Is WST in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold WST.

Key Stats

Last 12 months
Results
Revenue
$3.4B
+12.6% vs a year ago
Net income
$638.9M
+29.9% vs a year ago
EPS (diluted)
$8.91
+32.0% vs a year ago
Free cash flow
$453.4M
13.3% margin
Valuation
Market cap
$27.2B
69.7M shares
P/E
43.8
Price over 12 month EPS
Price to sales
8.0
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$464.1M
At Sep 30
Debt
$202.9M
At Sep 30
Shareholder equity
$3.0B
Buybacks
$685.3M
Last 12 months
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $2.8B$2.8BFY2021FY2022: $2.9B$2.9BFY2022FY2023: $2.9B$2.9BFY2023FY2024: $2.9B$2.9BFY2024FY2025: $3.1B$3.1BFY2025

From WST's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Oct 29). Last 12 months adds up the four latest quarters.

Next report
Feb 11
Estimated date · Time not announced
Reported EPS
$3.02
Quarter ended Sep 2026
Year ago EPS
$1.92
+57.3% on a GAAP basis
Revenue
$874.5M
+8.7% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: $1.78Dec '24Mar 2025: $1.23Mar '25Jun 2025: $1.82Jun '25Sep 2025: $1.92Sep '25Dec 2025: $1.82Dec '25Mar 2026: $1.92Mar '26Jun 2026: $2.15Jun '26Sep 2026: $3.02Sep '26Latest $3.02
Revenue by quarter
Dec 2024: $748.8MDec '24Mar 2025: $698.0MMar '25Jun 2025: $766.5MJun '25Sep 2025: $804.6MSep '25Dec 2025: $805.0MDec '25Mar 2026: $844.9MMar '26Jun 2026: $872.3MJun '26Sep 2026: $874.5MSep '26Latest $874.5M
How WST moved after its last 8 reports
Average move the session after a report ±11.7%
Oct 29, 2026Time not announced+3.2%
Jul 23, 2026Time not announced−0.8%
Apr 23, 2026Time not announced+12.9%
Feb 12, 2026Time not announced−1.0%
Oct 23, 2025Time not announced+10.9%
Jul 24, 2025Time not announced+22.8%
Apr 24, 2025Time not announced−3.5%
Feb 13, 2025Time not announced−38.2%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on WSTStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on WST
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on WST

Technical Analysis

WST · as of the Nov 20 close · updated each morning
Moving sideways

The stock sits between its 20 and 50 day averages. It is 17% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 43). The nearest support is the swing low (Nov 6) at $386.88, and the nearest resistance the Pivot at $392.97.

Short trendNeutral
Long trendBullish
MomentumWeak
StretchNormal
VolatilityNormal, 2.8%/day
Key levels
$438.2752 week high+12.3%
$420.66Swing high (Nov 16)+7.8%
$406.5520 day average+4.2%
$398.23Pivot R1+2.0%
$392.97Pivot+0.7%
$390.30Last close
$386.88Swing low (Nov 6)−0.9%
$386.5350 day average−1.0%
$385.04Pivot S1−1.3%
$367.68100 day average−5.8%
$325.66200 day average−16.6%
$223.8352 week low−42.7%
Indicators
RSI (14)43.25Middle of its rangeNeutral
MACD4.83Below its signal lineBearish
Stochastic29.3Middle of its rangeNeutral
ADX (14)32.9Trending down
Williams %R-89.9Oversold below −80, overbought above −20Oversold
CCI (20)-127.1Oversold below −100, overbought above 100Oversold
Rate of change−2.4%Change over 10 sessionsBearish
ATR (14)$11.06Typical daily range, 2.8% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
What happened before, for WST

What happened before

See how WST did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow WST usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How WST has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2005.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for WSTHow many large options trades hit WST, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

WST Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲436 buying vs 373 selling
  • ▼Held by funds -2.0 pts
  • ▲Funds holding +44
  • ▲Superinvestors: 4 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding881837+5.3%
In funds' top 1069−33.3%
Held by funds99.3%101.3%−2.0 pts
New / increased125 / 311144 / 305−2.9%
Reduced / sold out302 / 71258 / 63+16.2%
Put/call ratio0.742.73−73.0%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See WST institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

WST Insider Trading

All filings →
Insider trading · 12 months
Insiders are only selling
Bought$00 buys · 0 insiders
Sold$6.6M4 sales · 2 insiders
41% of the selling was under pre-arranged trading plans.
2026-04 sold $1.1M2026-09 sold $5.4MDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Sep 15Annette F FavoriteSr. VP & Chief HR OfficerSale plan7,524$355.03$2.7M
Sep 8Annette F FavoriteSr. VP & Chief HR OfficerSale8,135$340.81$2.8M
Apr 27Chad WintersVP, Chief Accounting OfficerSale896$300.67$269K
Apr 27Annette F FavoriteSr. VP & Chief HR OfficerSale2,817$305.20$860K
Every insider buy and sale for WST over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See WST insider trades →

From SEC Form 4 filings by WST's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

WST Stock Buybacks

See all S&P 500 buybacks →
Spent, 12 months
$685.3M
2.5% yield
Left in program
$314.7M
1.2% of value
Shares outstanding, 12 months
−3.2%
Fewer shares
Last quarter
$231.0M
Sep 2026
Avg price paid, last quarter
$348.11
664K shares bought
S&P 500 rank by spending
#244 of 358
 
Spent each quarter, last 3 yearsTop bar $297.6M
Dec 2023: $177.0M, average price $345.56Mar 2024: $267.0M, average price $365.87Jun 2024: $187.2M, average price $367.48Sep 2024: $52.3M, average price $306.34Dec 2024: $54.4M, average price $314.06Mar 2025: $133.5M, average price $242.63Jun 2025: $515K, average price $222.56Sep 2025: $0Dec 2025: $0Mar 2026: $297.6M, average price $243.57Jun 2026: $158.3M, average price $293.88Sep 2026: $231.0M, average price $348.11
Dec 2023Sep 2026
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.

From the company's 10-Q filed Oct 29, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether WST is in one of them and how their past WST trades turned out.

WST in the AI portfolios
Loading…

WST News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered WST in an article yet. Here's the latest on the wider market.

WST in the news

WST Congress Trades

All congress trades →
Trades, 12 months
0
Buys
0
Sells
0
People
0
Last filed Aug 13
Who traded WST · since 2015
Latest 5 filings of 20
$1K – $15KTraded Jul 22, 2025Filed Aug 13, 2025
$1K – $15KTraded Jun 17, 2025Filed Aug 13, 2025
$1K – $15KTraded Apr 8, 2025Filed May 8, 2025
$1K – $15KTraded Feb 25, 2025Filed Mar 27, 2025
$1K – $15KTraded Feb 13, 2025Filed Mar 6, 2025
PersonTypeAmountTradedFiledDelay
Lisa McClainR · MISell$1K – $15KJul 22, 2025Aug 13, 202522 d
Lisa McClainR · MIBuy$1K – $15KJun 17, 2025Aug 13, 202557 d
Rob BresnahanR · PASell$1K – $15KApr 8, 2025May 8, 202530 d
Rob BresnahanR · PABuy$1K – $15KFeb 25, 2025Mar 27, 202530 d
Jared MoskowitzD · FLSell$1K – $15KFeb 13, 2025Mar 6, 202521 d

From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data

About West Pharmaceutical Services

West designs and manufactures containment and delivery systems for injectable drugs and other healthcare products. Its Proprietary Products segment makes stoppers, seals, syringe and cartridge components, vials, and devices that let patients inject drugs at home, along with analytical lab services. Its Contract-Manufactured Products segment builds custom devices and components for pharmaceutical, diagnostic, and medical device customers. Customers include biologic, generic, and pharmaceutical drug makers, and the company is based in Exton, Pennsylvania.

Headquarters
Exton, PA